Chris Giordano
President and Chief Executive Officer at Tenax Therapeutics
Raleigh-Durham-Chapel Hill Area
Find your path to Chris
375 people in our graph share verified history with Chris — schools, employers, funds. One of them is your warm intro.
Jan HammerunlockedChris: together at University of Oxford (1995)
×2Chris: together at University of Oxford
×4Chris: together at University of San Diego
Chris: together at The University of North Carolina at Chapel Hill
President and Chief Executive Officer at Tenax Therapeutics
Intro paths
→
In turn, Chris can intro founders to Tenax Therapeutics's investors below.
Tenax Therapeutics's investors · 1
Experience
- Tenax TherapeuticsChief Executive Officercurrent2021 — presentNorth Carolina, United States
- IQVIAPresident at IQVIA Biotech2018 — 2021Raleigh-Durham, North Carolina Area
- IQVIAGlobal VP, TA Head: Cardiovascular Renal Metabolic2015 — 2018RTP
- IQVIAGlobal Vice President2008 — 2018RTP, North Carolina, USA
- PPDGeneral Manager2006 — 2008
- PPDDirector2001 — 2006
Skills & more
Executive LeadershipClinical DevelopmentClinical TrialsPharmaceutical IndustryDrug DevelopmentStrategyStrategic PlanningBusiness StrategyInternational BusinessBusiness DevelopmentAcquisition IntegrationPatient Engagement
+12 more
Cost ManagementGCPProject ManagementRegulatory AffairsGo-to-market StrategyBiotechnologyDiabetesPharmacovigilanceClinical MonitoringMergers & Acquisitions (M&A)BiopharmaceuticalsIntegrationFrom Chris's professional profile.
Frequently asked questions
- Who is Chris Giordano?
- President and Chief Executive Officer at Tenax Therapeutics
- Where does Chris Giordano work?
- Chris Giordano is President and Chief Executive Officer at Tenax Therapeutics.
- Where did Chris Giordano go to school?
- Chris Giordano studied at The University of North Carolina at Chapel Hill (MA, English); University of Oxford (Associate Student, English Language and Literature/Letters); University of San Diego (BA, English).
Same school
Also attended The University of North Carolina at Chapel Hill488
Clint MyersInvestor at RevolutionMahati SridharPartner, Rise of the Rest at RevolutionEric WagnerVP of Research and Data at Redpoint VenturesSoul DayanInvestor at True VenturesAlex LimInvestor at IVP (Institutional Venture Partners)Alex TaubPrincipal at QED Investors
+ 482 more
Also attended University of Oxford1,752
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 1,746 more
Also attended University of San Diego120
Raychel BailonVP of Finance at Felicis VenturesJoe HorsmanInvestor at Madrona Venture GroupKelli McKeirnanDirector of Administration at Westlake Village BioPartnersJason CorselloFounder & General Partner at Acadian Ventures Management, LlcNick GeannacopulosGrowth Investor at Five Elms CapitalGraham WagnerInvestor at Silversmith Capital Partners
+ 114 more
Shared employers
Also worked at Tenax Therapeutics2
Also worked at IQVIA82
Scott DonohueSenior Director, Market Access at Deerfield Management CompanyAlain HuriezVenture Partner at Advent Life SciencesDana Marohn SpiliotisPartner at Operator CollectiveRoel DekkersInvestment manager at NoaberMaulik MehtaManaging Partner at Excelerate Health VenturesJeanne HechtDigital Pharma Advisor at Excelerate Health Ventures
+ 76 more
Also worked at PPD31
John PotthoffDigital Pharma Advisor at Excelerate Health VenturesLisa WisniewskiManaging Director at Global BioAccess FundBunny EllerinChief Ecosystem Officer at Aegis VenturesAnil S. JinaExecutive in Residence at Iaso VenturesAnne JohnsonChief Accounting Officer at atai Life SciencesNan HowardInvestor at Eshelman Ventures, LLC
+ 25 more